Latest News About Projectpuma

Updated 2026-05-21 01:06

I don’t have live access to the latest feeds in this moment, but I can share what’s publicly known about “ProjectPuma” up to recently and how to verify the newest updates.

Direct answer

What I can do to help you get the latest

How to verify quickly yourself

If you can specify which ProjectPuma you mean (organization, sector, or country), I’ll pull together the latest updates with concise summaries and citations.

Sources

Press Release Distribution and Management

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

www.globenewswire.com

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Neratinib is a...

www.pumabiotechnology.com

Puma | The Independent

The latest breaking news, comment and features from The Independent.

www.independent.co.uk

Pumas

Read the latest UK headlines, on NewsNow. UK news, analysis and opinion from around the world.

www.newsnow.co.uk